Tariffs

News

After all the threats, it seems President Trump's tariffs on pharmaceuticals are coming to fruition, and a lot sooner than expected.

News

Lilly has named Houston as the second of four locations for new manufacturing facilities that are central to a $27bn investment programme in the US.

News

GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.

News

This week saw both Gilead Sciences and Amgen start to fulfil pledges to step up capital investments in new US facilities.

Sales & Marketing

In order to discuss the current unsettled landscape, and just how tariffs might affect patients, pharmaphorum spoke with Orr Inbar of QuantHealth.

News

Roche's Genentech unit has started work on a $700m manufacturing facility in North Carolina, part of a promised $50bn US investment programme.